Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab Switch in Etanercept-Treated Ankylosing Spondylitis
NCT02489760Phase 4Unknown
- Sponsor
- Chung Shan Medical University
- Start
- Jul 2008
- Primary completion
- Dec 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of adalimumab in ankylosing spondylitis (AS), sponsored by Chung Shan Medical University. Status: unknown.
02
Drugs
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT02489760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02489760.